Cardiovascular Risk in Survivors of Cancer
- 384 Downloads
Purpose of Review
Survivors of childhood and adult cancers face increased risk of cardiovascular disease. We review the current evidence base and guidelines for this rapidly growing population.
Research continues to show that cardiovascular disease is an important cause of morbidity and mortality in cancer survivors. Cardiotoxicity related to chemotherapy and radiotherapy accounts for part of this increased risk. There is emerging evidence that cancer and cardiovascular disease share a similar biology and risk factors.
At present, there are several guidelines and consensus recommendations for the management of cardiovascular risk in cancer survivors. The evidence base is accumulating though additional research is necessary to demonstrate improved outcomes and comparative effectiveness.
KeywordsSurvivorship Cardiotoxicity Chemotherapy-associated cardiomyopathy Screening guidelines
Compliance with Ethical Standards
Conflict of Interest
Henry Chen Zheng, Laura Onderko, and Sanjeev A. Francis declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
- 1.https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=445089. Accessed 4 Jan 2017.
- 3.http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed 15 Jan 2017.
- 4.http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 10 Jan 2017.
- 5.•• Moslehi JJ. Cardiovascular toxic effects of targeted cancer therapies. Longo DL, ed. N Engl J Med. 2016;375(15):1457–1467. doi: 10.1056/NEJMra1100265. This review provides a comprehensive overview of cardiovascular toxicity due to novel targeted cancer therapies.
- 7.Hahn VS, Lenihan DJ, Ky B. Cancer therapy–induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc. 2014;3(2):–e000665. doi: 10.1161/JAHA.113.000665.
- 11.Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015; doi: 10.1161/CIRCULATIONAHA.114.013777.
- 15.•• Lancellotti P, Nkomo VT, Badano LP, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26(9):1013–32. doi: 10.1016/j.echo.2013.07.005. This expert consensus document provides a nice review of radiation-associated heart disease as well as practical guidelines for the practicing clinician. CrossRefPubMedGoogle Scholar
- 16.Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014;35(10):612–23. doi: 10.1093/eurheartj/eht114.CrossRefPubMedGoogle Scholar
- 24.Hunt SA, Abraham WT, Chin MH, et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):e391–479.CrossRefPubMedGoogle Scholar
- 28.National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Survivorship Guidelines. Version 2. 2016.Google Scholar
- 29.•• Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2014;27(9):911–39. This expert consensus provides a nice review of chemotherapy-associated heart disease and provides practical guidelines for the practicing clinician particularly in regard to the role of cardiac imaging in the screening, diagnosis, and follow-up of patients with cardiotoxicity. CrossRefGoogle Scholar
- 33.Children’s Oncology Grop. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers Version 4.0. 2013.Google Scholar
- 36.United Kingdon Children’s Cancer Study Late Effects Group. Therapy based long term follow up practice statement. 2005.Google Scholar
- 39.Kremer LC, Mulder RL, Oeffinger KC, et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60(4):543–9.CrossRefPubMedGoogle Scholar
- 44.Iyer NS, Mitchell HR, Zheng DJ, Ross WL, Kadan-Lottick NS. Experiences with the survivorship care plan in primary care providers of childhood cancer survivors: a mixed methods approach. Supportive Care In Cancer : Official Journal Of The Multinational Association Of Supportive Care In Cancer. 2017 May;25(5):1547–55. doi: 10.1007/s00520-016-3544-0. Epub 2017 Jan 3.